Skip to main
University-wide Navigation

Lt. Gov. Coleman, Female Legislators Highlight UK’s Ovarian Cancer Screening Program

Lt. Gov. Coleman and several of Kentucky’s female legislators joined UK HealthCare to highlight the work of the Markey Cancer Center's Ovarian Cancer Screening Program.

New Markey Initiative Helps Affiliates Deliver Cancer Care Closer to Home

The initiative aims to create a connected, integrated statewide cancer provider network. 40% of all new cancer cases in Kentucky are directly or indirectly cared for by Markey.

Preventing Cancer Recurrence with Coffee? Markey Launches Unique Clinical Trial

The UK Markey Cancer Center has officially launched a unique new clinical trial to test whether Artemisia annua extract can prevent ovarian cancer recurrence.

Markey’s ACTION Program Develops Cancer Education Curriculum for Appalachian Schools

The curriculum includes information on cancer data and risk factors in the region, follows national and state science and health education standards, and is tailored to cultural aspects of Appalachian Kentucky.

Markey Joins Nationwide Effort to Encourage Resumption of Cancer Screening, Treatment

The University of Kentucky Markey Cancer Center is teaming up with the National Comprehensive Cancer Network® (NCCN®), the American Cancer Society (ACS) and other leading cancer organizations across the country to endorse the resumption of cancer screening and treatment during the ongoing COVID-19 pandemic.

What to Know About Radon in Your Home

January is National Radon Action Month, a time to raise awareness of the health effects of radon and take action to lower your risk.

Markey Study Shows Kentucky Endometrial Cancer Patients Have Higher Rates of DACH1 Mutation

A new study by UK Markey Cancer Center researchers shows that DACH1 mutations are prevalent in Kentucky patients with endometrial cancer, suggesting that DACH1 may be a candidate biomarker for future trials with immunotherapy.

Williams Named Assistant Director for Cancer Health Equity at Markey

A major initiative of Williams and the Markey Community Impact Office will be the organization and expansion of Markey’s research and outreach portfolio that is focused on reducing cancer and other health disparities based on race/ethnicity, socioeconomic status, etc.

UK Study Shows FDA-approved Leukemia Drug May Help Treat Metastatic Melanoma

Building on these findings, Plattner and Markey oncologists are now collaborating with the pharmaceutical company Novartis to develop a Phase I clinical trial to test the safety and effectiveness of using nilotinib in relapsed melanoma patients.

Evers Elected to the National Academy of Medicine

Election to the Academy is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.

Filter News

Type of news story
UK Research Unit
news topic
Research news series